Research map: Disease modification in lupus nephritis: towards a pathophysiology-based treatment paradigm

Back to the article

Papers in this map

  1. Sex differences in immune responses · Sabra L. Klein · 2016 · 6646 citations · Cited by this paper
  2. Community power building to reduce inequities in access to health care · 2026 · Related
  3. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus · Michelle Petri · 2012 · 5391 citations · Cited by this paper
  4. Insights from integrative spatial transcriptomics in sepsis-associated acute kidney injury · 2026 · Related
  5. Circulating mitochondrial DAMPs cause inflammatory responses to injury · Qin Zhang · 2010 · 3844 citations · Cited by this paper
  6. Sequential therapeutic approach for the management of osteoporosis in people with chronic kidney disease · 2026 · Related
  7. Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial · Sandra Navarra · 2011 · 2099 citations · Cited by this paper
  8. A path to reduce chronic kidney disease burden in Samoa · 2026 · Related
  9. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide · Roberto Lande · 2007 · 1912 citations · Cited by this paper
  10. The first-in-human combined bladder and kidney transplant · 2026 · Related
  11. How dying cells alert the immune system to danger · Hajime Kono · 2008 · 1747 citations · Cited by this paper
  12. Clinical practice recommendations for the diagnosis and management of nephropathic cystinosis · 2026 · Related
  13. A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus · Richard Alan Furie · 2011 · 1694 citations · Cited by this paper
  14. The versatile roles of long non-coding RNAs in kidney disease · 2026 · Related
  15. Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease · Christian Lood · 2016 · 1614 citations · Cited by this paper
  16. Large language models in healthcare · 2026 · Related
  17. Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis · Abdul Hakkim · 2010 · 1494 citations · Cited by this paper
  18. Mental health and kidney disease · 2026 · Related
  19. Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study · Brad H. Rovin · 2012 · 1471 citations · Cited by this paper
  20. Lupus nephritis · 2025 · Related
  21. Efficacy and safety of rituximab in moderately‐to‐severely active systemic lupus erythematosus: The randomized, double‐blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial · Joan T. Merrill · 2009 · 1419 citations · Cited by this paper
  22. Trial of Anifrolumab in Active Systemic Lupus Erythematosus · Eric Francis Morand · 2019 · 1387 citations · Cited by this paper
  23. Mitochondria in innate immune responses · Andrew Phillip West · 2011 · 1384 citations · Cited by this paper
  24. Toll-like receptor 9–dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE · Jane Y. Tian · 2007 · 1376 citations · Cited by this paper
  25. Neutrophils Activate Plasmacytoid Dendritic Cells by Releasing Self-DNA–Peptide Complexes in Systemic Lupus Erythematosus · Roberto Lande · 2011 · 1321 citations · Cited by this paper
  26. Netting Neutrophils Induce Endothelial Damage, Infiltrate Tissues, and Expose Immunostimulatory Molecules in Systemic Lupus Erythematosus · Eneida C. Villanueva · 2011 · 1265 citations · Cited by this paper
  27. Therapy of Lupus Nephritis · Howard A. Austin · 1986 · 1194 citations · Cited by this paper
  28. THE EFFECT OF A HORMONE OF THE ADRENAL CORTEX (17-HYD ROXY-11-DEHYDROCORTICOSTERONE: COMPOUND E) AND OF PITUITARY ADRENOCORTICOTROPIC HORMONE ON RHEUMATOID ARTHRITIS · Philip S. Hench · 1949 · 1184 citations · Cited by this paper
  29. Distinct Effector B Cells Induced by Unregulated Toll-like Receptor 7 Contribute to Pathogenic Responses in Systemic Lupus Erythematosus · Scott A. Jenks · 2018 · 1145 citations · Cited by this paper
  30. Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases · Michel F. Gilliet · 2008 · 1139 citations · Cited by this paper
  31. Mycophenolate Mofetil or Intravenous Cyclophosphamide for Lupus Nephritis · Ellen M. Ginzler · 2005 · 1133 citations · Cited by this paper
  32. Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis · Gerald B. Appel · 2009 · 1124 citations · Cited by this paper
  33. Toll-like Receptor 7 and TLR9 Dictate Autoantibody Specificity and Have Opposing Inflammatory and Regulatory Roles in a Murine Model of Lupus · Sean R. Christensen · 2006 · 1103 citations · Cited by this paper
  34. Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus · Andréas Mackensen · 2022 · 1101 citations · Cited by this paper
  35. CD19 CAR T-Cell Therapy in Autoimmune Disease — A Case Series with Follow-up · Fabian Müller · 2024 · 1085 citations · Cited by this paper
  36. Revision of the International Society of Nephrology/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices · Ingeborg M. Bajema · 2018 · 1071 citations · Cited by this paper
  37. Cyclophosphamide and cancer: golden anniversary · Ashkan Emadi · 2009 · 1059 citations · Cited by this paper
  38. Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis · Richard Alan Furie · 2020 · 1036 citations · Cited by this paper
  39. Efficacy of Mycophenolate Mofetil in Patients with Diffuse Proliferative Lupus Nephritis · Tak Mao Chan · 2000 · 960 citations · Cited by this paper

Source: OpenAlex (CC0)